Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
NIHON PARKERIZING, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 0.1%
4095 NIHON PARKERIZING CO., LTD. 【J-GAAP】
Earnings ReportNIHON PARKERIZING CO., LTD. <4095> [TSE Prime] announced its financial results after the market closed on February 10th (16:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) was 14.1 billion yen, a 0.1% decrease compared to the same period last year. Progress toward the full-year plan of 18.5 billion yen was 76.7%, also surpassing the five-year average of 71.7%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to decrease 24.8% from the same period last year to 4.31 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit amounted to 5.34 billion yen, an increase of 1.1% compared to the same period last year. However, the operating profit margin decreased from 12.4% in the same period last year to 11.6%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 91,040 | 11,308 | 14,695 | 9,275 | 80.4 | 73.7 | Feb 7, 2024 | J-GAAP |
| Apr - Dec, 2024 | 96,457 | 11,306 | 14,193 | 9,559 | 81.5 | 71.2 | Feb 12, 2025 | J-GAAP |
| Apr - Dec, 2025 | 101,016 | 11,035 | 14,184 | 9,374 | 84.4 | 76.7 | Feb 10, 2026 | J-GAAP |
| YoY | +4.7% | -2.4% | -0.1% | -1.9% | +3.6% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 69,548 | 7,861 | 11,029 | 7,218 | 61.8 | 25 | May 13, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 66,266 | 7,171 | 9,658 | 6,339 | 58.4 | 25 | Nov 10, 2025 | J-GAAP |
| YoY | -4.7% | -8.8% | -12.4% | -12.2% | -5.4% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 125,085 | 15,258 | 19,945 | 13,194 | 114.4 | 40 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 132,281 | 14,998 | 19,936 | 13,112 | 112.2 | 50 | May 13, 2025 | J-GAAP |
| Mar, 2026 Guidance | 131,000 | 14,000 | 18,500 | 12,000 | 110.6 | 50 | May 13, 2025 | J-GAAP |
| YoY | -1.0% | -6.7% | -7.2% | -8.5% | -1.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 33,724 | 4,169 | 5,286 | 3,665 | 31.2 | 12.4 | Feb 12, 2025 | J-GAAP |
| Jan - Mar, 2025 | 35,824 | 3,692 | 5,743 | 3,553 | 30.4 | 10.3 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 31,876 | 3,413 | 4,033 | 2,810 | 24.7 | 10.7 | Aug 7, 2025 | J-GAAP |
| Jul - Sep, 2025 | 32,858 | 3,416 | 4,809 | 2,851 | 25.4 | 10.4 | Nov 10, 2025 | J-GAAP |
| Oct - Dec, 2025 | 36,282 | 4,206 | 5,342 | 3,713 | 33.4 | 11.6 | Feb 10, 2026 | J-GAAP |
| YoY | +7.6% | +0.9% | +1.1% | +1.3% | +7.0% |
Related Articles
Carna Biosciences, Continue Net Income Turns to Loss
AWA PAPER, Oct-Dec (3Q) Ordinary Profit Decreases by 80%, Decides to Continue No Dividend Policy
Integral, 66% Decrease in Net Income for the Last Fiscal Year, Current period performance is undisclosed., Increased Previous Year's Dividend by 3 Yen, Plan to Continue the 37 Yen Policy This Fiscal Year as Well
BeMap, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
Kyoritsu Computer & Communication, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.6 times, Oct-Dec Ordinary Profit Increases by 2.3 times
Toyo Seikan Group, Net Income Forecast for the Fiscal Year Revised Upward by 7%, Exceeded Record Profit Forecast
Nippon Chemical, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 41%, Oct-Dec Ordinary Profit Decreases by 38%
AnGes, The Current Fiscal Year's Net Income to Widen
COACH A, 28% Increase in Net Income for The Current Fiscal Year
IVY COSMETICS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.0 times, Oct-Dec Ordinary Profit Loss Widens